Abstract
Sickle cell disease in patients undergoing open heart procedures presents a multitude of challenges to the medical staff. With improved techniques of cardiopulmonary bypass, surgery, and anesthesia for treating patients with sickle cell disease, perfusionists will likely encounter patients with this genetic disorder on a more frequent basis. A 40-year-old black woman was admitted to our institution with recurrent Staphylococcus epidermidis and sepsis. She underwent transesophageal echocardiography and cardiac catheterization and was subsequently diagnosed with severe aortic insufficiency. The aortic valve was replaced. Herein, we report our experience in the preoperative, perioperative, and postoperative management of this patient. We present a concise update on the current literature and techniques used by others in similar cases, and we provide a brief section on future considerations to assist fellow practitioners in recognizing this disease and meeting the accompanying challenges.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Balasundaram S., Duran C. G., al-Halees Z., Kassay M. Cardiopulmonary bypass in sickle cell anaemia. Report of five cases. J Cardiovasc Surg (Torino) 1991 Mar-Apr;32(2):271–274. [PubMed] [Google Scholar]
- Cameron A. A., McCord C. W., Bertles J. F. Successful replacement of aortic and mitral valves with ball valve prostheses in a patient with rehumatic heart disease and SC hemoglobinopathy. Am J Cardiol. 1971 Mar;27(3):318–321. doi: 10.1016/0002-9149(71)90311-0. [DOI] [PubMed] [Google Scholar]
- Craenen J., Kilman J., Hosier D. M., Weinberger M. Mitral valve replacement in a child with sickle cell anemia. J Thorac Cardiovasc Surg. 1972 May;63(5):797–799. [PubMed] [Google Scholar]
- Head C. A., Brugnara C., Martinez-Ruiz R., Kacmarek R. M., Bridges K. R., Kuter D., Bloch K. D., Zapol W. M. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest. 1997 Sep 1;100(5):1193–1198. doi: 10.1172/JCI119631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Journois D., Pouard P., Greeley W. J., Mauriat P., Vouhé P., Safran D. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines, and complement components. Anesthesiology. 1994 Nov;81(5):1181–27A. doi: 10.1097/00000542-199411000-00011. [DOI] [PubMed] [Google Scholar]
- Kingsley C. P., Chronister T., Cohen D. J., Parrish J. M., Drew R., Bongiovanni M. B. Case 2--1996. Anesthetic management of a patient with hemoglobin SS disease and mitral insufficiency for mitral valve repair. J Cardiothorac Vasc Anesth. 1996 Apr;10(3):419–424. doi: 10.1016/s1053-0770(96)80108-x. [DOI] [PubMed] [Google Scholar]
- Leachman R. D., Miller W. T., Atias I. M. Sickle cell trait complicated by sickle cell thrombi after open-heart surgery. Am Heart J. 1967 Aug;74(2):268–270. doi: 10.1016/0002-8703(67)90288-8. [DOI] [PubMed] [Google Scholar]
- Métras D., Coulibaly A. O., Ouattara K., Longechaud A., Millet P., Chauvet J. Open-heart surgery in sickle-cell haemoglobinopathies: report of 15 cases. Thorax. 1982 Jul;37(7):486–491. doi: 10.1136/thx.37.7.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wenham P. W., Scott G. L., Wisheart J. D. Red cell survival after aortic valve replacement with Björk-Shiley prosthesis in presence of sickle-cell trait. Br Heart J. 1978 Jun;40(6):703–704. doi: 10.1136/hrt.40.6.703. [DOI] [PMC free article] [PubMed] [Google Scholar]